Visit Greenlight Guru's Virtual Booth

Learn more about us and chat with our team

The post-COVID Value Shift & How MedTech Companies can Capitalize

A session by Richard Charter
Vice President MedTech Market Access - Europe & Asia Pacific, Alira Health

Register to watch this content

By submitting your email you agree to the terms
Watch this content now

About this talk

The ongoing COVID-19 pandemic has fundamentally shifted the perception of value globally. The healthcare industry, and MedTech (Devices, Diagnostics and Digital Health) stand to benefit enormously. While the world waits for a vaccine, it has been MedTech companies and their solutions that have protected healthcare workers, kept patients alive, and been the focus of government policy and investment. The policy and funding shifts have been aligned to value-based healthcare principals, of which MedTech was already a leader. Discover how you can align your organization, and engage with key stakeholders to capitalize on this massive shift in value perception.

Takeaways:

  • How the fundamental structure of healthcare is set to change

-How this fundamental change will benefit MedTech companies

-What you need to do in order to make this change sustainable within your organization